A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).

Doctors worldwide should diagnose obesity differently, relying on broader criteria and taking into account when the condition causes ill-health, according to a new framework drawn up by experts and endorsed by 76 medical organizations internationally.

By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that question. This group, called the Lancet Commission, and organised by the journal of that name, have developed a better way of diagnosing obesity—one that distinguishes when it has become pathological.

More than a billion people are estimated to be living with obesity worldwide and prescription weight-loss drugs are in high demand. The report, published in The Lancet Diabetes &

Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure.

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and over-diagnosing people who don't currently deal with the negative health consequences of obesity.

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same health challenges.

The new definition proposed by the Lancet Diabetes & Endocrinology Commission, a group of 58 leading experts from various medical specialties and countries, moves beyond a simple cutoff mark for Body Mass Index (BMI),

Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced approach that could help with treatment